Frequency of IFNγ-producing T cells correlates with seroreactivity and activated T cells during canine Trypanosoma cruzi infection
Open Access
- 23 January 2014
- journal article
- Published by Springer Nature in Veterinary Research
- Vol. 45 (1) , 6
Abstract
Vaccines to preventTrypanosoma cruziinfection in humans or animals are not available, and in many settings, dogs are an important source of domestic infection for the insect vector. Identification of infected canines is crucial for evaluating peridomestic transmission dynamics and parasite control strategies. As immune control ofT. cruziinfection is dependent on humoral and cell-mediated immune responses, we aimed to define a serodiagnostic assay and T cell phenotypic markers for identifying infected dogs and studying the canineT. cruzi-specific immune response. Plasma samples and peripheral blood mononuclear cells (PBMCs) were obtained from forty-two dogs living in aT. cruzi-endemic region. Twenty dogs were known to be seropositive and nine seronegative by conventional serologic tests two years prior to our study. To determine canine seroreactivity, we tested sera or plasma samples in a multiplex bead array against eleven recombinantT. cruziproteins. Ninety-four percent (17/18) of dogs positive by multiplex serology were initially positive by conventional serology. The frequency of IFNγ-producing cells in PBMCs responding toT. cruzi correlated to serological status, identifying 95% of multiplex seropositive dogs. Intracellular staining identified CD4+and CD8+T cell populations as the sources ofT. cruzilysate-induced IFNγ. Low expression of CCR7 and CD62L on CD4+and CD8+T cells suggested a predominance of effector/effector memory T cells in seropositive canines. These results are the first, to our knowledge, to correlateT. cruzi-specific antibody responses with T cell responses in naturally infected dogs and validate these methods for identifying dogs exposed toT. cruzi.Keywords
This publication has 38 references indexed in Scilit:
- Testing the Efficacy of a Multi-Component DNA-Prime/DNA-Boost Vaccine against Trypanosoma cruzi Infection in DogsPLOS Neglected Tropical Diseases, 2011
- Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of ArgentinaMicrobes and Infection, 2010
- Changes inTrypanosoma cruzi–Specific Immune Responses after Treatment: Surrogate Markers of Treatment EfficacyClinical Infectious Diseases, 2009
- The steady-state transcriptome of the four major life-cycle stages of Trypanosoma cruziBMC Genomics, 2009
- Strong Host-Feeding Preferences of the Vector Triatoma infestans Modified by Vector Density: Implications for the Epidemiology of Chagas DiseasePLOS Neglected Tropical Diseases, 2009
- High Throughput Selection of Effective Serodiagnostics for Trypanosoma cruzi infectionPLOS Neglected Tropical Diseases, 2008
- Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas diseaseNature Medicine, 2008
- Kinetoplastids: related protozoan pathogens, different diseasesJournal of Clinical Investigation, 2008
- Domestic dogs and cats as sources ofTrypanosoma cruziinfection in rural northwestern ArgentinaParasitology, 2006
- CD8+ T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase EpitopesPLOS Pathogens, 2006